Drug Shortage Report for APO-WARFARIN

Last updated on 2018-07-03 History
Report ID 50162
Drug Identification Number 02242927
Brand name APO-WARFARIN
Common or Proper name WARFARIN
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) WARFARIN SODIUM
Strength(s) 4MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100 BTL & 500 BTL
ATC code B01AA
ATC description ANTITHROMBOTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-05-18
Estimated end date 2018-06-26
Actual end date 2018-06-26
Shortage status Resolved
Updated date 2018-07-03
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2018-07-03 French Compare
v3 2018-07-03 English Compare
v2 2018-05-23 French Compare
v1 2018-05-23 English Compare